Blood-Test Patents Debated at High Court as Einstein Invoked
This article is for subscribers only.
U.S. Supreme Court justices grappled with the reach of federal patent law, touching on both fire-building techniques and Albert Einstein’s discoveries during arguments over diagnostic medical tests.
Today’s one-hour session, which centered on a dispute between Nestle SA’s Prometheus unit and the Mayo Clinic, produced few clear answers. The justices sought to draw what proved to be a fine line between natural phenomena, which can’t be patented, and applications of those principles, which can be.